|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1250 H STREET NW, SUITE 1102 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Franklin Lakes |
State | NJ |
Zip Code | 07417 |
Country | USA |
|
5. Senate ID# 5767-12
|
||||||||
|
6. House ID# 329070000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Ann Gosier, Vice President Government Relations/Public Policy/Reimbursement |
Date | 04/21/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention
S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention
S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention
H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention
S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention
H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention
S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention
S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention
H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention
H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention
H.R. 4352, To provide $30,000,000 in funding to the Department of Education to provide assistance to public school districts for the prevention of drug resistant infections, Issues relating to HAI/MRSA surveillance and prevention
S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention
H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ann |
Gosier |
|
|
|
Christine |
Scullion |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 1909, Medicare Safe Needle Disposal Coverage Act of 2007, Issues relating to sharps and safe needle disposal
H.R. 3251, Medicare Safe Needle Disposal Coverage Act of 2007, Issues relating to sharps and safe needle disposal
S. 2404, Medicare Advanced Laboratory Diagnostics Act of 2007, To provide appropriate levels of reimbursement for diagnostic tests
H.R. 1321, Medicare Advanced Laboratory Diagnostics Act of 2007, To provide appropriate levels of reimbursement for diagnostic tests
S. 2465, A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program, Issues related to vaccine delivery
H.R. 4702, Vaccines for Children Access Act of 2008, Issues related to vaccine delivery
S. 2464, A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare part B, Issues related to vaccine delivery
H.R. 4704, Medicare Improvement Act of 2004, Issues related to vaccine delivery
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christine |
Scullion |
|
|
|
Ann |
Gosier |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 2029, Physician Payments Sunshine Act of 2007, Issues related to medical device company/physician relationship
H.R. 5605, Physican Payments Sunshine Act of 2008, Issues related to medical device company/physician relationship
S. 2467, A bill to amend the Social Security Act, the Federal Food, Drug, and Cosmetic Act, and the Pubic Health Service Act to ensure a sufficient supply of vaccines, and for other purchases. Issues related to vaccine delivery
H.R. 4703, Vaccine Shortage Preparedness Act of 2008, Issues related to vaccine delivery
S. 2466, A bill to amend the Public Health Service Act to increase the availability of vaccines, and for other purposes, Issues related to vaccine delivery
H.R. 4705, Vaccines for the Uninsured Adult Act of 2008, Issues related to vaccine delivery
S. 2221, Transparency in Medical Device Pricing Act of 2007, Issues relating to disclosure of pricing information for specified categories of products
S. 569, Vaccines for the Future Act of 2007, Issues related to vaccine delivery
H.R. 1391, Vaccines for the Future Act of 2007, Issues related to vaccine delivery
H.R. 5501, To authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to HIV/AIDS and Tuberculosis
S. 968, Stop Tuberculosis (TB) Now Act of 2007, Issues related to tuberculosis prevention and treatment
H.R. 1567, Stop Tuberculosis (TB) Now Act of 2007, Issues related to tuberculosis prevention and treatment
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ann |
Gosier |
|
|
|
Anthony |
Lakavage |
|
|
|
Christine |
Scullion |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 2351, To amend the Internal Revenue code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products, Issues related to support for medical research into infectious diseases
H.R. 4200, To amend the Internal Revenue code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products, Issues related to support for medical research into infectious diseases
H.R. 1496, Beating Infections through Research and Development Act of 2007, Issues relating to providing incentives for vaccine research
H.R. 2138, Investment in America Act of 2007, To make permanent the research and development tax credit and strengthen the alternative simplified credit
S. 2209, Research Credit Improvement Act of 2007, Issues related to research and development tax credit
H.R. 1712, Research and Development Tax Credit Act of 2007, Issues related to research and development tax credit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ann |
Gosier |
|
|
|
Christine |
Scullion |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 1041, Employee Free Choice Act of 2007, Issues related to amending the National Labor Relations Act
H.R. 800, Employee Free Choice Act of 2007, Issues related to amending the National Labor Relations Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ann |
Gosier |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |